While most small cap health stocks dream of commercialisation, healthcare companies at an early stage get excited about achieving Orphan Drug Designation.
Achieving this won't be as meaningful to the bottom line as a stock receiving regulatory approval, but it is a big step nonetheless. If and when commercialisation is achieved, this will have been a…
FY25 was finally the year ASX Real Estate Stocks broke out of their post-COVID slump, netting an average return of 17%. Of course, there were losers too, but they were in the minority. Of 66 ASX real estate stocks, 38 were winners, 5 were flat, and there were 23 'losers'.
But the sector has officially emerged…
Let's look at Meta Platforms (NDQ:META), a company that changed its name in 2021 thinking that the metaverse would be as big as the Internet. Well, there's some way to go there. Same with virtual reality.
But if there's another 3bn+ social network, let's hear about it. Facebook may have 'lost its gloss' post the Cambridge…
Botanix Pharmaceuticals (ASX:BOT) crashed over 50% back on Tuesday after an update that left investors disappointed. A crash of this magnitude would suggest the FDA knocked back its drug or that it failed a clinical trial.
With Botanix having commercialised its treatment, neither was the case, so it'd have to be a pretty bad sales update.…
You may've heard the expression to 'beat the market'. What does this mean? Well, it depends on the context in which it is said.
What is meant by the phase 'beating the market'
If a company beats the market, perhaps it has outperformed its competitors. But if an investor, whether an individual or a fund manager,…
Most people invest in stocks for capital gains (in other words for selling the stock for more than they bought it for), but it is possible to create a passive income from stocks and we look over how investors can do that.
Investing in shares can be a way to generate passive income. If you invest…
Kogan shares (ASX:KGN) have been volatile in the past couple of years, but is a better future ahead of it? At first glance, it may not appear a good pick given softening consumer demand, intense competition and negative earnings right now. But the company appears in better shape when you take a deeper dive - arguably…
It is a New Financial Year, so it's time to outline 11 Top ASX Stocks to Buy in FY26. Why 11 you might ask? Because 11 is the number of 'GICS' (Global Industry Classification Sectors) on the ASX, and we're picking one from each sector.
Our 11 Top ASX Stocks to Buy in FY26!
Energy: Ampol…
Modern technology allows Australian investors to trade international stocks just like local shares.
But going abroad might be daunting for investors who have never done it before, even those who are experienced with Australian equities. It is not impossible, though, and this article will outline how to set up your trading account to trade international shares.
How to…
In the high inflationary environment we're in, investors will hear companies talk about margins. What are companies talking about? Why are margins so important? And how can companies maintain them in a high-inflationary environment.
What is a company's profit margin?
A company's margin, also known as profit margin, is the ratio of net profit to sales revenue.…
